510(k) K971494

VIRAZYME INFLUENZA ID TEST FOR INFLUENZA TYPES A AND B VIRUSES by Zymetx, Inc. — Product Code GNX

K971494 is an FDA 510(k) premarket notification submitted by Zymetx, Inc. for the device "VIRAZYME INFLUENZA ID TEST FOR INFLUENZA TYPES A AND B VIRUSES". The FDA issued a decision of Substantially Equivalent on September 10, 1997. The device falls under product code GNX (Antigens, Cf (Including Cf Control), Influenza Virus A, B, C), a Class I device regulated under 21 CFR 866.3330. Zymetx, Inc. has at least 3 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 10, 1997
Date Received
April 24, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antigens, Cf (Including Cf Control), Influenza Virus A, B, C
Device Class
Class I
Regulation Number
866.3330
Review Panel
MI
Submission Type